SCHEMBL21717474

SCHEMBL21717474

Clc1ccc2cc3[nH]c4ccc(Cl)cc4c3cc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHUK O15111 1/20 0.50
▸ F11 P03951 1/20 0.47
▸ LMNA P02545 2/20 0.44
▸ MEN1 O00255 6/20 0.44
▸ KMT2A Q03164 6/20 0.44
▸ PTGS2 P35354 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ ABCC4 O15439 1/20 0.44
▸ C5 P01031 1/20 0.44
▸ PTGS1 P23219 1/20 0.44
▸ PDE4D Q08499 1/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ CASP1 P29466 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ RXFP1 Q9HBX9 1/20 0.44
▸ CYP2A6 P11509 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21451721 0.89 PARP1 (0.50) CHUKF11LMNAMEN1KMT2A
SCHEMBL21448352 0.89 MEN1 (0.51) CHUKLMNAMEN1KMT2APTGS2
SCHEMBL30180727 0.89 MEN1 (0.51) CHUKLMNAMEN1KMT2APTGS2
SCHEMBL21448386 0.87 AHR (0.57) CHUKLMNAMEN1KMT2AMAPT
SCHEMBL30180806 0.87 AHR (0.57) CHUKLMNAMEN1KMT2AMAPT
SCHEMBL21448183 0.87 AHR (0.57) CHUKLMNAMEN1KMT2AMAPT
SCHEMBL30180942 0.87 AHR (0.57) CHUKLMNAMEN1KMT2AMAPT
SCHEMBL550449 0.83 CHUK (0.60) CHUKLMNAMEN1KMT2APTGS2
SCHEMBL607827 0.83 CHUK (0.64) CHUKLMNAMEN1KMT2APTGS2
SCHEMBL29453525 0.83 CHUK (0.64) CHUKLMNAMEN1KMT2APTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-12-07 — — US disclosed
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same CYP1A1, CYP1B1, CRY1 CHUK 2905/4885F11 661/4885LMNA 2047/4885
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1A1, CYP1B1, CRY1 CHUK 2905/4885F11 661/4885LMNA 2047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback